NASC stock number: N2110858
donor stock number: e3 E3V #22
other name: ect3-2/ECT3-Venus L2
Resource Type: seed
Availability: available
Donors:- Laura Arribas Hernandez
- Peter Brodersen
Donation Date: 08/30/2021
Date Released: 09/27/2021
Description:
ect3-2 mutant (CS2110124) expressing the ECT3-Venus protein fusion under the control of the corresponding endogenous ECT3 promoter (ECT3p:ECT3-Venus-ECT3t). ect3-2 mutant plants were transformed by floral dipping. Kanamycin resistant. Homozygous for the transgene.
Growth Requirement: none
Marker: kanamycin
Background: Col (Columbia)
ABRC Comment:
Format Shipped: 100 seeds per vial
Base / Commercial Price: $15 / $120
Germplasm
2
left slanting of roots
Arabidopsis thaliana 3702
Additional Information
DOI | PubMed |
---|---|
10.1105/tpc.17.00833 | 29643069 |
10.1242/dev.189134 | 32611605 |
Transgene | Description | Promoter | Reporter | Marker |
---|---|---|---|---|
ECT3p:ECT3-Venus-ECT3t | ECT3-Venus protein fusion with the native ECT3 terminator driven by the ECT3 native promoter | ECT3p | Venus | kanamycin |
Quality Control Comments
There is no quality control data for this stock.